LeapZipBlog: Steve Blade

Steve Blade's blog

3857 blogs

Melanoma Cancer Diagnostics Market Demonstrates a Spectacular Growth 2018 to 2028

August 30, 2019 by Steve Blade  

The report on the melanoma cancer diagnostics market provides key insights, forecast, and in-depth analysis on the market. The melanoma cancer diagnostics market report also includes macro-economic and micro-economic factors playing an important role in the growth of the market. Market dynamics such as drivers, trends, opportunity, and challenges are also offered in the study. The melanoma cancer diagnostics market has also been analyzed on the basis of key regions and countries. Qualitative and quantitative analysis of the melanoma cancer diagnostics market is also included in the research study. According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=57

Segment-wise analysis of the melanoma cancer diagnostics is highlighted in the report to identify and provide details on the existing market opportunities. The melanoma cancer diagnostics market is segmented on the basis of test type and end user. These segments are further divided into sub-segments to offer better understanding of melanoma cancer diagnostics market.

Diagnostic accuracy for melanoma varies significantly with potential financial implications. With advanced diagnostics technologies, the cost of diagnostic procedures, screening, treatment, and medical follow-up is also increasing. According to the study published in the American Journal of Preventive Medicine, in 2007-2011, the average annual cost for skin cancer increased by 126%. Economic burden of skin cancer treatment is significantly increasing with a substantial increase in cost in diagnostics and treatment for melanoma. Leading companies profiled in the report include Cancer Genetics, Inc., Myriad Genetics Inc. Abbott Laboratories, Foundation Medicine, Inc., and Pathway Genomics Corporation 

With a rise in melanoma related deaths across various countries, melanoma diagnostics and therapeutics is significantly increasing. Government initiatives, along with the advancement in technology is also driving the growth of melanoma cancer diagnostics. Notable initiatives include,

  • European Skin Care Foundation (ESCF) is strongly focusing on establishing skin cancer centers across Europe. ESCF is also supporting research activities with an emphasis on innovative modalities for diagnosis and treatment.
  • To effectively manage melanoma in New Zealand and Australia, initiatives have been taken by governments in both the countries for early detection and holistic treatment. The Ministry of Health in New Zealand has established National Cancer Program to provide high quality and timely treatment for cancer.
  • The Ministry of Health in New Zealand, in partnership with various institutions, is likely to hold cancer control conference in 2019 to discuss major challenges and identify possible solutions.
  • The Department of Health in Australia review of evidence on effectiveness of public awareness campaigns to increase awareness for need of skin checks among people, with strategies to target high risk groups.

Have Any Query?? Ask Our Industry Expert:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=57

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Read Full PR Here:

https://www.factmr.com/media-release/43/melanoma-cancer-diagnostics-market

 

 

 

 

Melanoma Cancer Diagnostics Market Demonstrates a Spectacular Growth 2018 to 2028

August 30, 2019 by Steve Blade  

The report on the melanoma cancer diagnostics market provides key insights, forecast, and in-depth analysis on the market. The melanoma cancer diagnostics market report also includes macro-economic and micro-economic factors playing an important role in the growth of the market. Market dynamics such as drivers, trends, opportunity, and challenges are also offered in the study. The melanoma cancer diagnostics market has also been analyzed on the basis of key regions and countries. Qualitative and quantitative analysis of the melanoma cancer diagnostics market is also included in the research study. According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=57

Segment-wise analysis of the melanoma cancer diagnostics is highlighted in the report to identify and provide details on the existing market opportunities. The melanoma cancer diagnostics market is segmented on the basis of test type and end user. These segments are further divided into sub-segments to offer better understanding of melanoma cancer diagnostics market.

Diagnostic accuracy for melanoma varies significantly with potential financial implications. With advanced diagnostics technologies, the cost of diagnostic procedures, screening, treatment, and medical follow-up is also increasing. According to the study published in the American Journal of Preventive Medicine, in 2007-2011, the average annual cost for skin cancer increased by 126%. Economic burden of skin cancer treatment is significantly increasing with a substantial increase in cost in diagnostics and treatment for melanoma. Leading companies profiled in the report include Cancer Genetics, Inc., Myriad Genetics Inc. Abbott Laboratories, Foundation Medicine, Inc., and Pathway Genomics Corporation 

With a rise in melanoma related deaths across various countries, melanoma diagnostics and therapeutics is significantly increasing. Government initiatives, along with the advancement in technology is also driving the growth of melanoma cancer diagnostics. Notable initiatives include,

  • European Skin Care Foundation (ESCF) is strongly focusing on establishing skin cancer centers across Europe. ESCF is also supporting research activities with an emphasis on innovative modalities for diagnosis and treatment.
  • To effectively manage melanoma in New Zealand and Australia, initiatives have been taken by governments in both the countries for early detection and holistic treatment. The Ministry of Health in New Zealand has established National Cancer Program to provide high quality and timely treatment for cancer.
  • The Ministry of Health in New Zealand, in partnership with various institutions, is likely to hold cancer control conference in 2019 to discuss major challenges and identify possible solutions.
  • The Department of Health in Australia review of evidence on effectiveness of public awareness campaigns to increase awareness for need of skin checks among people, with strategies to target high risk groups.

Have Any Query?? Ask Our Industry Expert:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=57

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Read Full PR Here:

https://www.factmr.com/media-release/43/melanoma-cancer-diagnostics-market

 

 

 

 

Electrosurgery Devices Market Trends, Business Strategies and Opportunities with Top Key Players

August 30, 2019 by Steve Blade  

Electrosurgery devices are used during surgical procedures for management of blood loss, and surgical cutting. Electrosurgery devices are utilized in a variety of medical disciplines such as gastroenterology, abdominal surgery, urology, pneumology, and gynecology. This Fact.MR report analyzes the expansion of global electrosurgery devices market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Owing to technological innovations the electrosurgery  Devices  market in North America has demonstrated growth traction over the years. However, increased healthcare spending towards minimally invasive treatment in Asia-Pacific region is expected to propel the market forward, thus contributing as one of the fastest regional hub in electrosurgery devices market. However, factors such as significant product recalls owing to incompliance with FDA framework remain potential challenges for the growth trajectory.

Get sample of this report at

https://www.factmr.com/connectus/sample?flag=S&rep_id=126

Table of Content

1. Global Electro Surgery Devices Market - Executive Summary

2. Global Electro Surgery Devices Market Overview
2.1. Introduction
       2.1.1. Global Electro Surgery Devices Market Taxonomy
       2.1.2. Global Electro Surgery Devices Market Definition
2.2. Global Electro Surgery Devices Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Electro Surgery Devices Market Y-o-Y Growth
2.3. Global Electro Surgery Devices Market Dynamics
       2.3.1. Drivers
       2.3.2. Restraints
       2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis 
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Electro Surgery Devices Market Analysis and Forecast By Product Type 
3.1. Global Electro Surgery Devices Market Size and Forecast By Product Type, 2012-2022
       3.1.1. Radiofrequency Electro Surgery Devices Electro Surgery Devices Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Electrocautery Devices Electro Surgery Devices Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. Ultrasonic Electro Surgery Devices Electro Surgery Devices Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region

To be Continue.........

Hospitals to be the Largest End-users of Electrosurgery Devices in the Market

Based on end-users, electrosurgery devices sales in specialized clinics will register the highest CAGR through 2022. Hospitals are estimated to remain dominant in the global market for electrosurgery devices. In addition, revenues from sales of electrosurgery devices in ambulatory surgical centres will account for more than one-fourth market share by 2022-end. Ambulatory surgical centres will be the second largest end-users of electrosurgery devices in the market by 2022-end.

Detailed overview of electrosurgery devices market spectrum presented in the report banks upon a robust research methodology comprising primary and secondary researches that divulge relevant and timely market intelligence figures. Voluminous information recorded in the report with the aid of these research approaches have been meticulously validated by in-house research analysts.

Electrosurgery Devices Market: Competition Landscape

This section of the report offers a detailed section on key contributors in electrosurgery devices market. A dashboard view of each of the mentioned profiles complete with detailed insights on their respective SWOT analysis along with detailed assessment of their product portfolio, market contribution, as well as recent developments have been slated to aid readers’ understanding about the competition spectrum.

Key players listed in Fact.MR’s report on the global electrosurgery devices market include B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew, Boston Scientific Corporation, Medtronic Plc, Erbe Elektromedizin GmbH, Bovie Medical Corporation, Heal Force Bio-meditech Holdings Limited, Johnson & Johnson Private Limited, and AngioDynamics, Inc.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=126

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Urodynamic Devices Market Trends, Business Strategies and Opportunities with Top Key Players

August 30, 2019 by Steve Blade  

According to the World Health Organization (WHO), 330,000 cases of bladder cancer have been diagnosed annually across the globe. In addition, the National Association of Incontinence has estimated 200 Mn people to be affected with urinary incontinence worldwide every year. These incidences have propelled demand for urodynamic devices, owing to rising clinical urgency. A number of healthcare initiatives are being taken for creating awareness about urological problems, along with the availability of treatment and diagnostics for urological disorders. For example, the initiative in Japan - “Let’s Talk and Think About Continence”, and the “Continence Awareness Week” conducted by Continence Foundation in the U.K. These initiatives have deprived people of the social stigma related to these problems, encouraging them to start consulting physicians, which in turn has been augmenting growth of the global urodynamic devices market.

With large scale prevalence of chronic disorders such as bladder cancer and urinary incontinence, demands for urodynamic devices is poised to remain robust. Further, substantial initiatives towards urinary incontinence awareness such as its underlying causes, symptoms, and potential remedies are likely to further reinforce growth.

Get sample of this report at

https://www.factmr.com/connectus/sample?flag=S&rep_id=168

In order to offer readers with up-to-date information about the latest advancements in the global urodynamic devices market, the report provides updates about market opportunities, which can benefit leading manufacturers of urodynamic devices. With continuous evolution of the healthcaresector, keeping a record of latest developments and trends is fundamental for urodynamic devices manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure provided in this section.

The World Health Organization (WHO) has estimated over 300,000 patients to be affected with bladder cancer annually around the world. The National Association of Incontinence estimates roughly 200 Mn population across the globe to be suffering from urinary incontinence every year. Incidences such as these have increased demand for urodynamic devices, along with the rise in clinical urgency. Numerous healthcare initiatives have been creating awareness about urological disorders, coupled with availability of diagnostics and treatment for urological problems. Some initiatives among these include “Continence Awareness Week” undertaken by the U.K.’s Continence Foundation, and Japan’s “Let’s Talk and Think About Continence”. These initiatives are depriving people of social stigma, encouraging them to consult physicians. The aforementioned factors will boost growth of the global urodynamic devices market in the upcoming years.

North America will Retain its Dominance in the Global Urodynamic Devices Market

North America will retain its dominance in the global market for urodynamic devices, in terms of revenues. This is primarily attributed to surging prevalence of target diseases in the region, coupled with the robust adoption of urodynamic products in a variety of diagnostic procedures, pharmaceutical as well as healthcare centers, and rising preference of urologists & urogynecologists for urodynamic tests.

Urodynamics Devices Market: Competition Landscape

Key players participating in the global urodynamic devices market include Albyn Medical Ltd., Boston Scientific Corporation, Medica SpA, Neomedix Systems Pty. Ltd., Dantec Dynamics A/S, CooperSurgical Inc., LABORIE, Verathon Inc., and Best Medical International Inc.

The report allows readers to maneuver competitive and tactical business strategies based on aforementioned insights and ensure sustained revenue pools in urodynamics devices market.  

Have Any Query?? Ask Our Industry Expert:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=168

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

 

 

 

Peptide Based Cancer Therapeutics Market Share, Trends, Business Strategy and Forecast 2017 to 2022

August 30, 2019 by Steve Blade  

Peptide based cancer therapeutics are yet to become widespread, but the initial low numbers certainly do not suggest any pessimism in the global market. With new developments in delivery, stability, modifications, and preclinical success, future growth potentials of such cancer therapeutics continue to intensify.  A slew of new peptides with positive preclinical results are entering into clinical trials that are focused on cancer treatment. Moreover, the application base of peptides is steadily expanding to other therapeutic areas as well. In the near future, the global peptide based cancer therapeutics market is likely to be influenced by the rising prevalence of cancer across the globe. WHO reveals that cancer is one of the leading causes of death worldwide, which accounted for more than 8 million deaths in 2015. Factor as such are expected to play an important role in boosting the popularity of peptide based cancer therapeutics further. In addition, various complications involved in conventional cancer therapeutics as well as the risk of sever side-effects are prompting medical professionals to utilise peptides in tumor and cancer treatment. Fact.MR’s latest report projects that the global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end, expanding at an impressive CAGR of 9.2% during the forecast period (2017-2022).

According to a report published by Fact.MR, the global peptide based cancer therapeutics market is poised to surpass the market valuation of US$ 11,000 Mn by the end of 2022, owing to multiple factors contributing to this boom.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=179

Medical institutions across the world are ramping up their efforts towards the development of effective therapeutic drugs for cancer treatment. In addition to this, investors are underpinning the initiatives of healthcare organizations by funding their researches. With the report produced by the World Health Organization (WHO) stating the occurrence of over 8 Mn deaths in 2015 backed by the pervasiveness of cancer, proliferating adoption of advanced peptide based cancer therapeutic is witnessed. A host of these factors have contributed to the growing size of the peptide-based cancer therapeutics market at the global level with an estimated CAGR of over 9% through 2022.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global peptide based cancer therapeutics market. Drug, distribution channel and region are key segments that define the growth of the global market for peptide based cancer therapeutics. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

North America To Lead The Global Peptide Based Cancer Therapeutics Market

In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region’s potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

An analysis of the supply chain and average pricing is discussed in the report to understand the dynamics of the peptide-based cancer therapeutics market. Evaluation of the attractiveness of the market has been carried out on the basis of region, drug, and distribution channel.

The regions analyzed in the report consist of Latin America, North America, Europe, Japan, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). The regions have been analyzed keeping the segments – drug and distribution channel and their revenue share to the global market in mind.

Valeant Pharmaceuticals International, Inc., Allergan plc, AbbVie Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Abbott, Pfizer Inc., and Johnson & Johnson are among the leading companies functioning in the global market for peptide based cancer therapeutics. Majority of these market players are actively focusing on further product development as well as channelizing their investments in R&D activities.  

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=179

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

 

 

Operating Room Equipment Market In-depth Analysis, Share and Insights Covering Market Share Forecast 2017 to 2022

August 30, 2019 by Steve Blade  

The report commences with a brief information of the global operating room equipment market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global operating room equipment market.  The Fact.MR study offers a detailed analysis and an accurate forecast of global operating room equipment market for the 2017-2022 period. The global operating room market is projected to grow at a CAGR of 6.2% during the forecast period.

 Owing to surged prevalence of chronic diseases and trauma cases there has been corresponding upswing in surgical procedures within sterile environments such as operation theatres, thereby necessitating adoption of technologically advanced operating room equipment to facilitate apt therapeutics for pathological and psychological ailments. Further, growing preferences for minimally invasive surgical procedures are also aimed at incurring favorable growth prospects for operating room equipment market in the coming years.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=192

Operating Room Equipment Market – Key Insights

  • The global operating room equipment grew at a significant CAGR of 5.3% during 2012-2016, on the back of increasing prevalence of pathological and physiological disorders along with continuous effort to improve healthcare industry across the globe.
  • Worldwide sales of operating room equipment closed in on a valuation of over US$ 29 billion, and is expected to record a Y-o-Y growth of 6.0% in 2019.
  • North America is envisaged to maintain its leading position in the operating room equipment market, accounting for a relatively large percentage of revenue share in 2018. Surge in the number of ambulatory surgical centers and heavy investments by hospitals to upgrade operating rooms are the key factors fuelling the market growth.
  • APEJ is likely to be the fastest-growing market for operating room equipment, expanding at a robust CAGR of 6.7% during the 2017-2022 period.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global operating room equipment market. Product type, end users, and region are key segments that define the growth of the global market for vaccine delivery devices. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included

Operating room equipment market: Competition Landscape

This section of the report offers a detailed section on key contributors in operating room equipment market. A dashboard view of each of the mentioned profiles complete with detailed insights on their respective SWOT analysis along with detailed assessment of their product portfolio, market contribution, as well as recent developments have been slated to aid readers’ understanding about the competition spectrum.

The study highlights detailed profiles of leading players in the global operating room equipment market which include Getinge AB, Stryker Corporation, Steris Plc, Hill-Rom Holdings, Inc., General Electric Company, KARL STORZ GmbH & Co. KG, Mizuho OSI, Inc., Medtronic, plc, Koninklijke Philips N.V., and Dragerwerk AG & Co. KGaA.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=192

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

 

Spine Devices Market Outlook and Opportunities in Grooming Regions

August 30, 2019 by Steve Blade  

At the time when low back ache has become rampant, plethora of medical devices for spinal diseases and injuries are being introduced. It becomes imperative to comprehend the presence or absence of an instrument or device along with identifying the complications linked with its use. Ergo, invaluable players in the spine devices market have high hopes on innovative devices with a minimally invasive approach aimal cord injury each year globally. In light of it, nanotechnology may aid in the treatment of spinal injury. The nanotechnology implants, also called as nanowire-coate electrodes has the ability to act as a neural interface and sensors. Along with enabling sufferers of spinal cord injuries to regain sensory functions, the nanotechnology could serve as the basis for novel applications.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=259

Table of Content

1. Global Spine Devices Market - Executive Summary

2. Global Spine Devices Market Overview
     2.1. Introduction
            2.1.1. Global Spine Devices Market Taxonomy
            2.1.2. Global Spine Devices Market Definition
     2.2. Global Spine Devices Market Size (US$ Mn) and Forecast, 2012-2022
            2.2.1. Global Spine Devices Market Y-o-Y Growth
     2.3. Global Spine Devices Market Dynamics
            2.3.1. Drivers
            2.3.2. Restraints
            2.3.3. Trends
     2.4. Supply Chain
     2.5. Cost Structure
     2.6. Pricing Analysis 
     2.7. Raw Material Sourcing Strategy and Analysis
     2.8. Procedure Numbers By Region
     2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Spine Devices Market Analysis and Forecast By Product 
     3.1. Global Spine Devices Market Size and Forecast By Product, 2012-2022
            3.1.1. Spinal Rods Spine Devices Market Size and Forecast, 2012-2022
                     3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.1.2. Market Share Comparison, By Region
                     3.1.1.3. Y-o-Y growth Comparison, By Region
            3.1.2. Spinal Screws Spine Devices Market Size and Forecast, 2012-2022
                     3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.2.2. Market Share Comparison, By Region
                     3.1.2.3. Y-o-Y growth Comparison, By Region
            3.1.3. Spinal Hooks Spine Devices Market Size and Forecast, 2012-2022
                     3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.3.2. Market Share Comparison, By Region
                     3.1.3.3. Y-o-Y growth Comparison, By Region
            3.1.4. Spinal Plates Spine Devices Market Size and Forecast, 2012-2022
                     3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.4.2. Market Share Comparison, By Region
                     3.1.4.3. Y-o-Y growth Comparison, By Region
            3.1.5. Spinal Cages Spine Devices Market Size and Forecast, 2012-2022
                     3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.5.2. Market Share Comparison, By Region
                     3.1.5.3. Y-o-Y growth Comparison, By Region

To be Continue............

A qualitative and quantitative information has been obtained for the forecast and assessment on the spine devices market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the spine devices is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.

Spine devices Market: Competitive Landscape

Major market players being instrumental for the growth of the spine devices market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis to provide a holistic picture of the competitive scenario of the spine devices market. A deep dive analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the spine devices market.

The report also profiles companies that are expected to remain active in the expansion of global spine devices market through 2022, which include Exactech, Inc., NuVasive, Inc., DePuy Synthes, Amedica Corporation, Braun Melsungen AG, Arthrocare, Medtronic Plc., K2M Group Holding, Inc., Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=259

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

 

 

 

Orthopedic Power Tools Market Plying for Significant Growth During 2017 to 2026

August 30, 2019 by Steve Blade  

Orthopedic power tools are used in the treatment and prevention of impairments caused by physical injuries, or birth-related disorders regarding musculoskeletal systems. Orthopedic power tools are devices manufactured for carrying out specific actions such as fixing implants, and drilling in surgical procedures. These are electrically operated devices that facilitate surgeons in performing surgeries with high precision and in lesser time. Large bone power tools, small bone power tools, and high speed power tools are included in the orthopedic power tools currently available in the orthopedic power tools market.

Fact.MR’s report provides a competitive landscape of the orthopedic power tools market  identifying key players in the market that include Misonix, CONMED Corporation, B Braun, Zimmer Biomet, Johnson & Johnson, and Stryker Corporation.  

Request Sample here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=334

Table of Content

Chapter 1 Global Outlook

Chapter 2 Global Orthopedic Power Tools Market - Executive Summary

Chapter 3 Global Orthopedic Power Tools Market Overview
3.1 Introduction
      3.1.1 Global Orthopedic Power Tools Market Taxonomy
      3.1.2 Global Orthopedic Power Tools Market Definition
3.2 Global Orthopedic Power Tools Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Orthopedic Power Tools Market Y-o-Y Growth
3.3 Global Orthopedic Power Tools Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Pricing Analysis
3.7 Procedure Numbers by Region
3.8 Key Regulations
3.9 PESTL Analysis
3.10 Product Lifecycle
3.11 Service Provider List
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Orthopedic Power Tools Market Analysis and Forecast 2012-2026
4.1 Global Orthopedic Power Tools Market Size and Forecast by Product Type, 2012-2026
      4.1.1 Large Bone Power Tools Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Small Bone Power Tools Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region

To be Continue...........

The report commences with a brief information of the global orthopedic power tools market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global orthopedic power tools market.

The Fact.MR report offers segmentation analysis & forecast to cover the wide scope of the global orthopedic power tools market. Key segments that define the growth of the global market for orthopedic power tools are modality, end-user, product type, and region. This segmentation analysis gives an in-depth country-wise forecast around all key parameters impacting the market expansion.

Based on modality, revenues from reusable orthopedic power tools’ worldwide sales will account for nearly three-fourth share of the market by 2026-end. However, reusable or disposable tools are expensive, require high maintenance costs, and are associated with risks regarding infection from patient. This has led surgeons toward adoption of single-use orthopedic power tools, which are convenient and cost-effective. Reusable orthopedic power tools will register the fastest expansion in the market through 2026.

Accounting for the largest market revenue share during 2017 to 2026, hospitals will remain the largest end-users of orthopedic power tools market. However, orthopedic clinics are projected to register the highest CAGR in the market through 2026. Revenues from ambulatory surgical centers will increase at a CAGR lower than those from orthopedic clinics, and higher than those from hospitals through 2026.

 Fact.MR’s report provides a competitive landscape of the orthopedic power tools market, identifying key players in the market that include Misonix, CONMED Corporation, B Braun, Zimmer Biomet, Johnson & Johnson, and Stryker Corporation.

For More Information Raise Enquiry Here:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=334

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Read Industry News at - https://www.industrynewsanalysis.com/

 

 

 

Cancer Profiling Market Share, Growth by Top Company Forecast to 2018 to 2028

August 30, 2019 by Steve Blade  

Fact.MR has compiled a study on cancer profiling market and published a new report titled, “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028.” The cancer profiling market report delivers intelligent and actionable insights that are derived based on thorough analysis of all the vital facets of the market. Cancer profiling market forecast derived in the report are based on exhaustive assessment such as SWOT analysis, associated industry assessment as well as mega and micro trends that hold significant influence on the growth of the cancer profiling market.

The Fact.MR report tracks the cancer profiling market for the period 2018-2028. According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.

Request Sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=358

Table of Content

1. Executive Summary – Global Cancer Profiling Market
   1.1. Market Summary
   1.2. Analysis Summary
   1.3. Megatrends in Cancer Profiling Market
   1.4. Opportunity Assessment
   1.5. Wheel of Fortune Opportunity Analysis
   1.6. Fact.MR View Point

2. Market Overview
   2.1. Market Introduction
   2.2. Market Definition
   2.3. Scope of the Report

3. Market Dynamics
   3.1. Macro - Economic Factors Influencing Demand
   3.2. Key Growth Drivers and Impact Analysis
   3.3. Industry Challenges and Restraints
   3.4. Forecast Factors and Relevance of Impact

4. Key Inclusions
   4.1. Regional Pricing Analysis by Test (2017)
   4.2. Cancer Epidemiology By Region, 2017
   4.2. PORTER's Analysis
   4.2. Cancer Profiling Regulatory Senario

To be Continue.....

The cancer profiling market is studied thoroughly for different facets such as types of cancer and associated diagnostic testing methods. In addition, regulation and reimbursement scenario is also considered to design the cancer profiling market structure. The cancer profiling market is segmented on the basis of product type, indication, end user and test type. The cancer profiling market is also studied for key regions to derive global forecast.

As genomic instability and acquisition of mutations are the hallmarks of cancer, tumor heterogeneity continues to pose challenges for the identification, testing and development of cancer biomarkers. These challenges reach to drug development landscape wherein their implementation in clinical drug trials is advancing at a staggering pace.

For these reasons, the landscape of cancer therapy seeks potential strategies for the development of robust biomarkers that complements the evolving cancer alterations, thereby enabling efficient tumor biopsies using cancer profiling. While ongoing cancer therapeutic scenario is lagging behind in biomarker development, considerable investments are in pipeline and their outcome is expected to aid in the progress of cancer profiling landscape in the future.

Cancer Profiling Market - Competitive Landscap

Few of the profiles players in the cancer profiling market report include F. Hoffmann La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific Inc, Abbott, Nanostring Technologies Inc,  Siemens AG, HTG Molecular Diagnostics, Inc, Perkin Elmer Inc, Agilent Technologies Inc, Negenomics Laboratory Inc, Genomic Health, Biogenex and Pacific Biosciences of California, Inc.

For More information Raise Enquiry

https://www.factmr.com/connectus/sample?flag=AE&rep_id=358

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Dual Chamber Prefilled Syringes Market Segmentation and Industrial Overview Forecasts 2017 to 2026

August 30, 2019 by Steve Blade  

According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-e. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for dual chamber prefilled syringes manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section. Dual chamber prefilled syringes have evolved to the stage where they are functionally useful for the packaging of lyophilized small volume parental drugs.

Glass will remain preferred product material for dual chamber prefilled syringes, mainly because of its non-reactive nature, and properties such as chemical and heat resistance. However sales of glass prefilled syringes will witness a comparatively slower expansion than plastic prefilled syringes through 2026.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

  • Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
  • In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
  • Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
  • On the basis of product type, conventional prefilled syringes are expected to account for the lion’s share of the market during 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.

Prefilled syringes have gained popularity owing to enhanced user safety, ease of use and the decline of potential dosage errors. At-home administration, self-administration and the surge of biologics are the primary aspects that trigger the growth of dual chamber prefilled syringes market. On account of low cost and adoption of self-administered drugs, conventional prefilled syringes are expected to be most preferred products in the market. Meanwhile, prefilled has become integral part of auto-injection segment of the drug delivery market, which needs prefilled cartridges.

Competitive Landscape

Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=486

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com